tiprankstipranks
Trending News
More News >
Eli Lilly & Co (DE:LLY)
XETRA:LLY
Germany Market
Advertisement

Eli Lilly & Co (LLY) Drug Pipeline

Compare
175 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Eloralintide, Macupatide
Obesity, Overweight, Diabetes Mellitus, Type 2
Phase II
Not Yet Recruiting
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Oct 09, 2025
Degludec, Ly3938577
Diabetes Mellitus, Type 2
Phase II
Not Yet Recruiting
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
Oct 09, 2025
Carboplatin, Bevacizumab, Gemcitabine, Paclitaxel, Pegylated Liposomal Doxorubicin, Topotecan, Mirv, Ly4170156
Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Neoplasm Metastasis
Phase III
Not Yet Recruiting
A Two-Part Phase 3 Study of LY4170156 in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
Oct 07, 2025
Ly4337713
Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms, Cholangiocarcinoma, Ovarian Neoplasms, Pancreatic Intraductal Neoplasms, Esophageal Neoplasms
Phase I
Not Yet Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Oct 07, 2025
Orforglipron
Urinary Incontinence,Stress
Phase III
Not Yet Recruiting
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Sep 24, 2025
Abemaciclib, Letrozole, Anastrozole, Ribociclib, Palbociclib, Fulvestrant, Exemestane, Ly4064809
Breast Neoplasms, Neoplasm Metastasis
Phase III
Not Yet Recruiting
A Study of LY4064809 With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Sep 12, 2025
Standard Of Care Antiemetic Therapies, Background Chemotherapy, Ly3537021
Neoplasms, Drug-Related Side Effects And Adverse Reactions, Vomiting, Nausea
Phase II
Not Yet Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Sep 05, 2025
Ly3537031
Healthy, Hepatic Insufficiency
Phase I
Not Yet Recruiting
A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment
Sep 03, 2025
Ly3537031
Healthy, Renal Impairment, Renal Insufficiency, End Stage Renal Disease (Esrd)
Phase I
Not Yet Recruiting
A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment
Sep 03, 2025
Orforglipron
Osteoarthritis
Phase III
Not Yet Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
Sep 02, 2025

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Eli Lilly & Co (LLY) have in its pipeline
      LLY is currently developing the following drugs: Eloralintide, Macupatide, Degludec, Ly3938577, Carboplatin, Bevacizumab, Gemcitabine, Paclitaxel, Pegylated Liposomal Doxorubicin, Topotecan, Mirv, Ly4170156. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis